Chronic Respiratory Questionnaire

1. Abstract

The Chronic Respiratory Questionnaire (CRQ), also widely designated in the clinical literature as the Chronic Respiratory Disease Questionnaire (CRDQ), is an internationally standardized, disease-specific evaluative instrument designed to measure health-related quality of life (HRQoL) in individuals diagnosed with chronic respiratory conditions, predominantly chronic obstructive pulmonary disease (COPD), severe asthma, bronchiectasis, and interstitial lung diseases. Developed in 1987 by Gordon H. Guyatt and colleagues at McMaster University, the instrument operationalizes the multidimensional biopsychosocial impact of chronic airflow limitation across four well-defined empirical domains: Dyspnea (5 individualized, patient-selected functional activities), Fatigue (4 items), Emotional Function (7 items), and Mastery (4 items), totaling 20 items. Each item is measured along a graded 7-point Likert-type response scale ranging from 1 (representing maximum impairment or worst health status) to 7 (indicating no impairment or optimal functioning). Psychometric evaluations consistently confirm high internal consistency reliability across subscales (Cronbach’s α typically spanning 0.78 to 0.91) and robust test-retest reliability intraclass correlation coefficients (ICCs ≥ 0.80 to 0.95). Structural equation modeling and confirmatory factor analyses demonstrate the robust stability of the four-factor multidimensional construct across both the original interviewer-administered format (CRQ-IA) and the standardized self-administered version (CRQ-SR). Crucially, the CRQ exhibits superior longitudinal responsiveness to therapeutic interventions—such as pulmonary rehabilitation, supplemental oxygen therapy, and bronchodilator regimens—establishing an established minimally important difference (MID) benchmark of 0.5 points per item on the 7-point scale. The CRQ remains an essential clinical endpoint in respiratory medicine, translational pulmonology, and health services research worldwide.

2. Keywords

Chronic Respiratory Questionnaire, CRQ, CRDQ, Health-Related Quality of Life, Chronic Obstructive Pulmonary Disease, Dyspnea, Fatigue, Mastery, Pulmonary Rehabilitation, Psychometrics, Evaluative Instrument, Minimally Important Difference.

3. Authors

The original Chronic Respiratory Questionnaire was formulated and validated by a multidisciplinary team of clinical epidemiologists and pulmonary specialists at McMaster University, Hamilton, Ontario, Canada:

• Gordon H. Guyatt, MD, MSc, FRCPC — Distinguished Professor, Department of Health Research Methods, Evidence, and Impact (HEI) and Department of Medicine, McMaster University, Hamilton, Ontario, Canada. Pioneer in evidence-based medicine and patient-reported outcome measures.
• L. Berman, MD — Department of Medicine and Department of Radiology, McMaster University Medical Centre, Hamilton, Ontario, Canada.
• M. Townsend, MSc — Research Methodologist, Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.
• V. A. Pugsley, RN — Clinical Research Coordinator, Chest Unit, St. Joseph’s Hospital and McMaster University, Hamilton, Ontario, Canada.
• Larry W. Chambers, PhD — Professor Emeritus, Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.

Subsequent standardized and cross-cultural validation efforts were led by numerous international working groups, notably including Peter J. Wijkstra, MD, PhD, and colleagues (1994) at the University of Groningen, Netherlands, who produced and validated the authoritative Dutch linguistic translation and adaptation, as well as Holger J. Schünemann, MD, PhD, who spearheaded the development and psychometric refinement of the self-administered and standardized dyspnea formats.

4. Purpose

The primary clinical and psychometric objective of the Chronic Respiratory Questionnaire (CRQ) is to capture, quantify, and track subtle yet clinically meaningful fluctuations in disease-specific functional capacity, symptom burden, and psychological well-being among patients suffering from severe chronic pulmonary impairment. While generic health status metrics—such as the Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) or the EuroQol 5-Dimension (EQ-5D)—offer broad population-level comparisons, they notoriously exhibit significant floor and ceiling effects and lack adequate sensitivity to detect therapeutic gains achieved through targeted respiratory therapeutics. Conversely, physiological indicators such as forced expiratory volume in one second (FEV₁), peak flow rates, and arterial blood gas concentrations correlate weakly to moderately with patients’ day-to-day functional performance, emotional distress, and perceived handicap. The CRQ was purposefully constructed as an evaluative instrument explicitly tailored to capture longitudinal change over time within individuals.

From an applied clinical perspective, the instrument fulfills three interconnected functions:

• Clinical Trial Endpoint Measurement: Serving as a primary or secondary patient-reported outcome measure (PROM) in randomized controlled trials evaluating the efficacy of pharmacotherapies (long-acting muscarinic antagonists, long-acting beta-agonists, inhaled corticosteroids), lung volume reduction surgery, non-invasive ventilation, and comprehensive pulmonary rehabilitation programs.
• Routine Clinical Practice Monitoring: Providing clinicians and interdisciplinary pulmonary rehabilitation teams with a granular diagnostic profile of individual functional limitations, enabling targeted adjustments to occupational therapy, physical conditioning, and psychological counseling.
• Health Services and Comparative Effectiveness Research: Establishing cost-effectiveness models, quality-adjusted life year (QALY) transformations, and real-world post-market surveillance of chronic respiratory care pathways.

The fundamental theoretical rationale driving the CRQ centers on individualization and patient-centeredness. Recognizing that two individuals with identical physiological impairment (e.g., FEV₁ at 35% of predicted normal) may experience profoundly divergent lifestyle disruptions based on their vocational demands, personal values, and physical environments, the original CRQ introduced an innovative individualized dyspnea assessment module. By empowering patients to identify activities that matter directly to their unique existence, the CRQ maximizes evaluative responsiveness and clinical relevance, bridging the historic divide between objective physiological lung function and subjective lived illness experience.

5. Psychological Construct

The Chronic Respiratory Questionnaire measures a multidimensional, hierarchical construct of respiratory-specific health-related quality of life. The 20 items operationalize four core latent dimensions:

1. Dyspnea (Items 1–5)

The dyspnea subscale captures the somatic perception of respiratory insufficiency, breathlessness, and physical exertion during meaningful activities of daily living. Dyspnea is not merely an afferent sensory signal; it constitutes a composite psychophysiological phenomenon involving sensory intensity, affective unpleasantness, and behavioral avoidance. In the classic CRQ formulation, the patient selects five specific, personally relevant physical activities from an extensive standardized catalog (or nominates idiosyncratic daily tasks) that provoke shortness of breath and are performed regularly. The patient then rates the magnitude of dyspnea experienced during each specific task over the preceding two weeks. By evaluating dyspnea across tailored activities (such as climbing stairs, carrying groceries, performing household chores, walking uphill, or dressing), the scale captures actual functional limitation rather than hypothetical exertion thresholds.

2. Fatigue (Items 8, 11, 15, 17)

Chronic systemic hypoxemia, systemic inflammation, mechanical work of breathing, and skeletal muscle deconditioning combine in pulmonary disease to generate profound, pervasive lethargy. The fatigue domain assesses the frequency and severity of physiological exhaustion, systemic depletion, and loss of physical vitality over the preceding 14-day recall window. This construct reflects the cognitive and physical weariness experienced by patients, differentiating transient exertional tiredness from the pervasive, debilitating fatigue characteristic of progressive respiratory failure.

3. Emotional Function (Items 6, 9, 12, 14, 16, 18, 20)

Living with chronic airflow limitation imposes severe psychological morbidity, including elevated rates of major depressive disorder and panic-related anxiety. The emotional function subscale measures affective destabilization directly secondary to respiratory illness. Items capture feelings of frustration, embarrassment resulting from coughing or audible wheezing in social settings, demoralization, discouragement, acute breathlessness-associated panic, irritability, and pervasive nervous tension. The construct reflects both state emotional turbulence and the existential strain of living with an incurable, progressive condition.

4. Mastery (Items 7, 10, 13, 19)

Rooted in cognitive behavioral formulations and self-efficacy theory, mastery reflects an individual’s perceived locus of control, self-management agency, and confidence in navigating chronic breathlessness and sudden respiratory exacerbations. Patients high in mastery perceive themselves as capable of mitigating dyspnea attacks through pacing, breathing techniques, medication management, and emotional regulation. Conversely, low mastery indicates helplessness, perceived vulnerability, and panic during respiratory decompensation.

6. Theoretical Framework

The conceptual architecture of the CRQ is grounded in the contemporary biopsychosocial paradigm of disease and aligns directly with the seminal Wilson and Cleary Model of Health-Related Quality of Life (1995). This model conceptualizes health outcomes along a progressive, multi-tiered causal continuum spanning five interrelated domains:

1. Biological and Physiological Variables: Pathophysiological indices such as bronchial airway obstruction, hyperinflation, loss of elastic recoil, and arterial blood gas perturbations.
2. Symptom Status: The conscious perception of physiological disruptions, primarily manifested as dyspnea, chronic sputum production, and systemic fatigue.
3. Functional Status: The ability to execute basic activities of daily living (BADLs) and instrumental activities of daily living (IADLs), heavily influenced by physical conditioning and environmental architecture.
4. General Health Perceptions: Subjective cognitive syntheses regarding overall well-being, vitality, and somatic resilience.
5. Overall Quality of Life: The overarching cognitive appraisal of life satisfaction within the context of illness constraints and subjective aspirations.

Within this framework, the CRQ intentionally circumvents direct physiological measurement (which correlates poorly with human experiential well-being) to measure the interface between Symptom Status (Dyspnea and Fatigue), Functional Status (activity-specific dyspnea limitation), and General Health Perceptions/Well-Being (Emotional Function and Mastery). Psychological theories of cognitive appraisal—most notably the transaction model of stress and coping formulated by Richard Lazarus and Susan Folkman—underpin the Mastery and Emotional Function subscales. When individuals confront the severe stressor of dyspnea, their primary appraisal evaluates the threat magnitude (e.g., suffocation fear), while secondary appraisal assesses available coping resources. The CRQ captures the direct emotional sequelae of this appraisal process, measuring how successfully the patient maintains psychological equilibrium in the face of progressive respiratory decline.

7. Validity

The CRQ has undergone rigorous cross-sectional and longitudinal psychometric validation across multiple global cohorts, diagnostic groups, and clinical environments.

Construct and Convergent Validity

Extensive validation studies confirm strong, theoretically congruent convergent associations between CRQ subscales and related clinical constructs. In original and subsequent validation cohorts, the CRQ Dyspnea domain correlates substantially with the Medical Research Council (MRC) dyspnea scale (correlations ranging from r = −0.58 to −0.72) and the Baseline Dyspnea Index (BDI). Moderate to strong convergent correlations emerge between the CRQ Dyspnea and Fatigue subscales and functional capacity parameters, including the 6-Minute Walk Test (6MWT; r = 0.40 to 0.62) and progressive cycle ergometry workload. The Emotional Function and Mastery subscales correlate robustly with established psychological inventories, demonstrating strong negative associations with the Hospital Anxiety and Depression Scale (HADS; r = −0.55 to −0.71 for anxiety and depression respectively) and the Beck Depression Inventory.

Discriminant Validity

The CRQ demonstrates outstanding discriminant validity by distinguishing between clinical subpopulations characterized by varying disease severity. Patients categorized according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) spirometric staging (Stages I through IV) exhibit statistically significant downward step-gradient trajectories in CRQ domain scores. Furthermore, the CRQ readily discriminates between stable outpatients and patients experiencing acute exacerbations of COPD requiring hospitalization, with mean domain score differentials exceeding 1.0 to 1.5 points on the 7-point scale.

Longitudinal Evaluative Validity and Responsiveness

The hallmark psychometric strength of the CRQ lies in its evaluative responsiveness. Guyatt and colleagues demonstrated that the CRQ achieves standardized response means (SRM) and effect sizes consistently exceeding 0.80 to 1.20 following comprehensive pulmonary rehabilitation programs—significantly outperforming generic instruments such as the SF-36 and Sickness Impact Profile (SIP). Jaeschke, Singer, and Guyatt (1989) established the benchmark for clinical interpretability: a change of 0.5 points per item on the 7-point scale represents the Minimally Important Difference (MID)—the smallest difference in score that patients perceive as beneficial and which mandates an alteration in clinical management. An alteration of 1.0 reflects a moderate clinical change, while an alteration of 1.5 represents a large, transformative clinical shift.

8. Reliability

The psychometric stability and precision of the CRQ have been verified through extensive international field testing using classical test theory methodologies.

Internal Consistency Reliability

Internal consistency analyses across diverse linguistic and cultural adaptations consistently yield Cronbach’s α coefficients exceeding the standard 0.70 benchmark for group comparisons, frequently fulfilling the ≥ 0.80 criterion desired for individual patient monitoring:

• Dyspnea Subscale: Cronbach’s α typically ranges from 0.80 to 0.88 in standardized formats (and ≥ 0.82 in individualized formats).
• Fatigue Subscale: Cronbach’s α consistently demonstrates values between 0.78 and 0.88.
• Emotional Function Subscale: Displaying high item coherence, Cronbach’s α ranges between 0.85 and 0.91 across both English and cross-cultural adaptations.
• Mastery Subscale: Cronbach’s α ranges from 0.76 to 0.86.

Test-Retest Reliability

In stable, non-interventional clinical control periods spanning 1 to 4 weeks, the CRQ demonstrates exceptional reproducibility. Intraclass correlation coefficients (ICCs) for test-retest reliability consistently register between 0.80 and 0.95 across all four subscales. Standard error of measurement (SEM) analyses reveal minimal score fluctuation during clinical stability, confirming that documented longitudinal changes above the 0.5 MID threshold reflect true physiological and psychosocial improvement rather than measurement error.

9. Factor Analysis

The latent structural foundation of the CRQ has been rigorously interrogated through both exploratory factor analysis (EFA) and confirmatory factor analysis (CFA) across diverse patient populations.

Exploratory Factor Analysis

Initial principal component and exploratory factor analyses utilizing varimax and oblimin rotations confirmed a clear four-dimensional latent structure corresponding to Dyspnea, Fatigue, Emotional Function, and Mastery. Items loaded robustly on their designated theoretical factors (typical primary loadings > 0.55 to 0.82), with minimal deleterious cross-loadings. Items capturing cognitive and physical energy (Items 8, 11, 15, 17) clustered uniquely onto the Fatigue axis, while items probing emotional distress, embarrassment, panic, and demoralization loaded cleanly onto the Emotional Function factor.

Confirmatory Factor Analysis and Structural Invariance

Subsequent structural equation modeling across international cohorts has formally tested the empirical fit of the hypothesized four-factor oblique model. CFA models demonstrate adequate to excellent goodness-of-fit indices across published literature:

• Comparative Fit Index (CFI): Values consistently range from 0.91 to 0.96, satisfying established psychometric criteria.
• Tucker-Lewis Index (TLI): Typical reports exceed 0.90 to 0.94.
• Root Mean Square Error of Approximation (RMSEA): Coefficients range from 0.048 to 0.068 (90% CI: [0.041, 0.075]), indicating low residual error.
• Standardized Root Mean Square Residual (SRMR): Values consistently settle below 0.06.

Measurement invariance testing across sexes, age strata, and disease severities confirms metric and scalar invariance, verifying that the CRQ functions equivalently across heterogeneous patient cohorts. While moderate inter-factor correlations exist—notably between Emotional Function and Mastery (r ≈ 0.55–0.65) and between Fatigue and Dyspnea (r ≈ 0.45–0.58)—multidimensional CFA models display substantially superior fit over single-factor unidimensional or two-factor physical/psychological collapsed models, cementing the multidimensional integrity of the 20-item instrument.

10. Instrument / Measurement Tool

• Instrument Name: Chronic Respiratory Questionnaire (CRQ) / Chronic Respiratory Disease Questionnaire (CRDQ).
• Test Type: Disease-specific, evaluative patient-reported outcome measure (PROM) / health-related quality of life survey.
• Administration Format: Originally developed as an Interviewer-Administered questionnaire (CRQ-IA); subsequently validated as a Self-Reported instrument (CRQ-SR) with individualized or standardized dyspnea options.
• Target Population: Adults and elderly individuals diagnosed with chronic airflow limitation, chronic obstructive pulmonary disease (COPD), refractory asthma, cystic fibrosis, or restrictive parenchymal lung disorders.
• Completion Time: Approximately 15 to 25 minutes for the original individualized interviewer-administered format; 10 to 15 minutes for the self-administered standardized format.
• Number of Items: 20 items.
• Subscale Breakdown:
  • Dyspnea: 5 items (Items 1, 2, 3, 4, 5 — patient-selected individualized physical activities).
  • Fatigue: 4 items (Items 8, 11, 15, 17).
  • Emotional Function: 7 items (Items 6, 9, 12, 14, 16, 18, 20).
  • Mastery: 4 items (Items 7, 10, 13, 19).
• Response Scale: 7-point Likert-type scale (e.g., 1 = Extremely short of breath / All of the time to 7 = Not at all short of breath / None of the time).
• Scoring Protocol: All items are scored on a 1 to 7 scale where 1 indicates the worst health status/maximum impairment and 7 indicates the best health status/no impairment. Positively phrased items and negatively phrased items are standardized such that higher scores invariably represent superior health status and better functioning. Scores are expressed as domain mean scores (sum of domain items divided by the number of items in that domain) or as domain total scores. The minimally important difference (MID) benchmark is 0.5 points per item.

11. Permissions & Fee and Test Year

The Chronic Respiratory Questionnaire was first formally published in 1987 by Dr. Gordon H. Guyatt and colleagues at McMaster University in Hamilton, Ontario, Canada. The formal legal copyright for the CRQ (including all its derivatives, such as the CRQ-IA, CRQ-SR, and international translations) is owned and retained by McMaster University.

The instrument is protected by international intellectual property law. Academic, non-commercial researchers, clinical investigators, and registered non-profit healthcare organizations may access and utilize the CRQ upon submitting a formal licensing agreement through the McMaster University Industry Liaison Office / MILO (or via authorized clinical outcome metric distributors such as Mapi Research Trust / ePROVIDE). While nominal administrative processing fees or fee waivers apply for non-funded academic research, commercial entities, including pharmaceutical corporations and medical device manufacturers conducting sponsored clinical trials, are required to pay standard licensing royalties. Modifying, re-translating, or commercially distributing the instrument without prior written authorization from McMaster University is strictly prohibited.

12. References

Guyatt, G. H., Berman, L. B., Townsend, M., Pugsley, S. O., & Chambers, L. W. (1987). A measure of quality of life for clinical trials in chronic lung disease. Thorax, 42(10), 773–778. https://doi.org/10.1136/thx.42.10.773

Jaeschke, R., Singer, J., & Guyatt, G. H. (1989). Measurement of health status: Ascertaining the minimal clinically important difference. Controlled Clinical Trials, 10(4), 407–415. https://doi.org/10.1016/0197-2456(89)90005-6

Lacasse, Y., Wong, E., Guyatt, G. H., King, D., Cook, D. J., & Goldstein, R. S. (1996). Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. The Lancet, 348(9035), 1115–1119. https://doi.org/10.1016/S0140-6736(96)04201-8

Puhan, M. A., Behnke, M., Frey, M., Grueter, T., Brandli, O., Lichtenschopf, T., Guyatt, G. H., & Schünemann, H. J. (2004). Self-administration and interviewer-administration of the Chronic Respiratory Questionnaire were comparable in patients with chronic obstructive pulmonary disease. Journal of Clinical Epidemiology, 57(4), 360–369. https://doi.org/10.1016/j.jclinepi.2003.09.011

Schünemann, H. J., Puhan, M., Goldstein, R., Jaeschke, R., & Guyatt, G. H. (2005). Measurement properties and interpretability of the Chronic Respiratory Disease Questionnaire (CRQ). COPD: Journal of Chronic Obstructive Pulmonary Disease, 2(1), 81–89. https://doi.org/10.1081/COPD-200053378

Wijkstra, P. J., TenVergert, E. M., Van Altena, R., Otten, V., Postma, D. S., Kraan, J., & Koeter, G. H. (1994). Reliability and validity of the Chronic Respiratory Questionnaire (CRQ). Thorax, 49(5), 465–467. https://doi.org/10.1136/thx.49.5.465

Wilson, I. B., & Cleary, P. D. (1995). Linking clinical variables with health-related quality of life: A conceptual model of patient outcomes. JAMA, 273(1), 59–65. https://doi.org/10.1001/jama.1995.03520250075037

13. Items of the Scale